Literature DB >> 20803415

High prevalence of normal tests assessing hypercortisolism in subjects with mild and episodic Cushing's syndrome suggests that the paradigm for diagnosis and exclusion of Cushing's syndrome requires multiple testing.

T C Friedman1, D E Ghods, H K Shahinian, L Zachery, N Shayesteh, S Seasholtz, E Zuckerbraun, M L Lee, I E McCutcheon.   

Abstract

Many Endocrinologists believe that a single determination of eucortisolism or a single demonstration of appropriate suppression to dexamethasone excluded Cushing's syndrome, except in what was previously thought to be the rare patient with episodic or periodic Cushing's syndrome. We hypothesize that episodic Cushing's syndrome is relatively common and a single test assessing hypercortisolism may not be sufficient to accurately rule out or diagnose Cushing's syndrome and retrospectively examined the number of normal and abnormal tests assessing hypercortisolism performed on multiple occasions in 66 patients found to have mild and/or episodic Cushing's syndrome compared to a similar group of 54 patients evaluated for, but determined not to have Cushing's syndrome. We found that 65 of the 66 patients with Cushing's syndrome had at least one normal test of cortisol status and most patients had several normal tests. The probability of having Cushing's syndrome when one test was negative was 92% for 23:00 h salivary cortisol, 88% for 24-h UFC, 86% for 24-h 17OHS, and 54% for nighttime plasma cortisol. These results demonstrated that episodic hypercortisolism is highly prevalent in subjects with mild Cushing's syndrome and no single test was effective in conclusively diagnosing or excluding the condition. Rather, the paradigm for the diagnosis should be a careful history and physical examination and in those patients in whom mild Cushing's syndrome/disease is strongly suspected, multiple tests assessing hypercortisolism should be performed on subsequent occasions, especially when the patient is experiencing signs and symptoms of short-term hypercortisolism. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20803415      PMCID: PMC2978784          DOI: 10.1055/s-0030-1263128

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  36 in total

1.  Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing's syndrome.

Authors:  T Mengden; P Hubmann; J Müller; P Greminger; W Vetter
Journal:  Clin Investig       Date:  1992-07

2.  The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma.

Authors:  R H SILBER; C C PORTER
Journal:  J Biol Chem       Date:  1954-10       Impact factor: 5.157

Review 3.  The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.

Authors:  J Newell-Price; P Trainer; M Besser; A Grossman
Journal:  Endocr Rev       Date:  1998-10       Impact factor: 19.871

Review 4.  Endocrine investigation: Cushing's syndrome.

Authors:  R J Ross; P J Trainer
Journal:  Clin Endocrinol (Oxf)       Date:  1998-08       Impact factor: 3.478

Review 5.  The Cushing syndrome: an update on diagnostic tests.

Authors:  T B Kaye; L Crapo
Journal:  Ann Intern Med       Date:  1990-03-15       Impact factor: 25.391

Review 6.  Cyclic Cushing's syndrome: a clinical challenge.

Authors:  J R Meinardi; B H R Wolffenbuttel; R P F Dullaart
Journal:  Eur J Endocrinol       Date:  2007-09       Impact factor: 6.664

7.  Late-night salivary cortisol as a screening test for Cushing's syndrome.

Authors:  H Raff; J L Raff; J W Findling
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

8.  Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.

Authors:  E H Oldfield; J L Doppman; L K Nieman; G P Chrousos; D L Miller; D A Katz; G B Cutler; D L Loriaux
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

Review 9.  Cyclic Cushing syndrome: definitions and treatment implications.

Authors:  Dennis A Velez; Marc R Mayberg; William H Ludlam
Journal:  Neurosurg Focus       Date:  2007       Impact factor: 4.047

10.  Assessment of endocrine function after transsphenoidal surgery for Cushing's disease.

Authors:  D R McCance; D S Gordon; T F Fannin; D R Hadden; L Kennedy; B Sheridan; A B Atkinson
Journal:  Clin Endocrinol (Oxf)       Date:  1993-01       Impact factor: 3.478

View more
  8 in total

1.  Hair cortisol in the evaluation of Cushing syndrome.

Authors:  Aaron Hodes; Maya B Lodish; Amit Tirosh; Jerrold Meyer; Elena Belyavskaya; Charalampos Lyssikatos; Kendra Rosenberg; Andrew Demidowich; Jeremy Swan; Nichole Jonas; Constantine A Stratakis; Mihail Zilbermint
Journal:  Endocrine       Date:  2017-02-13       Impact factor: 3.633

Review 2.  Mini-review of hair cortisol concentration for evaluation of Cushing syndrome.

Authors:  Aaron Hodes; Jerrold Meyer; Maya B Lodish; Constantine A Stratakis; Mihail Zilbermint
Journal:  Expert Rev Endocrinol Metab       Date:  2018-09-20

3.  Adrenal insufficiency in a child following unilateral excision of a dual-hormone secreting phaeochromocytoma.

Authors:  Annika Sjoeholm; Cassandra Li; Chaey Leem; Aiden Lee; Maria P Stack; Paul L Hofman; Benjamin J Wheeler
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-06-01

4.  Diagnosis of Cushing's disease in a patient with consistently normal urinary free cortisol levels: a case report.

Authors:  Kelley J Moloney; Jennifer U Mercado; William H Ludlam; Frances E Broyles
Journal:  Clin Case Rep       Date:  2016-11-09

Review 5.  Adrenal Hypercortisolism: A Closer Look at Screening, Diagnosis, and Important Considerations of Different Testing Modalities.

Authors:  Iacopo Chiodini; Arelys Ramos-Rivera; Alan O Marcus; Hanford Yau
Journal:  J Endocr Soc       Date:  2019-04-11

6.  Cyclic Subclinical Hypercortisolism: A Previously Unidentified Hypersecretory Form of Adrenal Incidentalomas.

Authors:  Rafael B Giorgi; Marcelo V Correa; Flávia A Costa-Barbosa; Claudio E Kater
Journal:  J Endocr Soc       Date:  2019-02-11

7.  Cushing's Syndrome in a Patient With Rathke's Cleft Cyst and ACTH Cell Hyperplasia Detected by 11C-Methionine PET Imaging-A Case Presentation.

Authors:  Karol Piotr Sagan; Elzbieta Andrysiak-Mamos; Leszek Sagan; Przemysław Nowacki; Bogdan Małkowski; Anhelli Syrenicz
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-22       Impact factor: 5.555

Review 8.  Toward a Diagnostic Score in Cushing's Syndrome.

Authors:  Leah T Braun; Anna Riester; Andrea Oßwald-Kopp; Julia Fazel; German Rubinstein; Martin Bidlingmaier; Felix Beuschlein; Martin Reincke
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-08       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.